# Natera Ovarian Cancer Detection Assay

> **NCT03485651** · — · TERMINATED · sponsor: **Natera, Inc.** · enrollment: 12 (actual)

## Conditions studied

- Adnexal Mass

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03485651
- **Lead sponsor:** Natera, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2017-12-14
- **Primary completion:** 2019-11-01
- **Final completion:** 2019-12-31
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Poor accrual
- **Last updated:** 2020-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03485651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03485651, "Natera Ovarian Cancer Detection Assay". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03485651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*